CONSOLIDATED STATEMENTS OF OPERATIONS (USD $)	3 Months Ended		204 Months Ended
	Oct. 31, 2012	Oct. 31, 2011	Oct. 31, 2012
Revenues, net	$ 0	$ 9,931	$ 5,110,784
Cost of Goods Sold	0	3,262	1,620,375
Gross profit	0	6,669	3,490,409
Operating Expenses:
Research and development	653,395	1,979,502	132,629,359
Research and development - related party	0	0	220,218
Selling and marketing	0	75,661	9,333,214
General and administrative	1,286,636	1,421,284	149,088,792
General and administrative - related party	0	0	314,328
Total Operating Expenses	1,940,031	3,476,447	291,585,911
Operating Loss	(1,940,031)	(3,469,778)	(288,095,502)
Other Income (Expense):
Miscellaneous income	0	0	686,303
Income from assets held for investment, net (Note 11)	1,042,868	712,075	5,377,125
Interest income	225	519	7,782,118
Interest expense	(117,975)	(34,921)	(69,126,657)
Change in fair value of derivative liabilities (Note 10)	358,714	3,128,459	(357,263)	[1]
Loss on extinguishment of debt	0	0	(14,134,068)
Net Income/(Loss) Before Undernoted	(656,199)	336,354	(357,867,944)
Minority Interest Share of Loss	0	0	3,038,185
Net income/(loss)	(656,199)	336,354	(354,829,759)
Preferred Stock Dividend (Note 9)	102,297	0	3,540,517
Net Income/(Loss) Available to Common Stockholders	$ (758,496)	$ 336,354	$ (358,370,276)
Net Income/(Loss) Per Common Share (Note 8)
Basic	$ (0.002)	$ 0.001
Diluted	$ (0.002)	$ 0.001
Shares used in computing earnings/(loss) per share (Note 8)
Basic	364,310,359	313,342,608
Diluted	364,310,359	313,348,032

[1] includes $5,981,403 as adjustment related to the adoption of FASB ASC Topic 815 in "Cumulative from November 2, 1995 (Date of Inception) to October 31, 2012" column. See Note 10 - Derivative Liabilities.